DOI:
10.1055/s-00000004
Aktuelle Neurologie
LinksClose Window
References
Pahwa R, Koller WC, Trosch RM. APO303 study investigators. et al
Subcutaneous apomorphine in patients with advanced
Parkinson's disease: A dose-escalation study with randomized,
double-blind, placebo-controlled crossover evaluation of a single dose.
J Neurol Sci 2007; 258: 137-143
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.